BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 22393903)

  • 1. A novel A20 (TNFAIP3) antibody (Ber-A20) can be used to detect unmutated A20 by immunohistology.
    Hirsch B; Grünbaum M; Wagner F; Bi Y; Lucka L; Du MQ; Stein H; Dürkop H
    Histopathology; 2012 May; 60(6B):E19-27. PubMed ID: 22393903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas.
    Honma K; Tsuzuki S; Nakagawa M; Tagawa H; Nakamura S; Morishima Y; Seto M
    Blood; 2009 Sep; 114(12):2467-75. PubMed ID: 19608751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
    Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
    J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low Protein A20 in Minor Salivary Glands is Associated with Lymphoma in Primary Sjögren's Syndrome.
    Johnsen SJ; Gudlaugsson E; Skaland I; Janssen EA; Jonsson MV; Helgeland L; Berget E; Jonsson R; Omdal R
    Scand J Immunol; 2016 Mar; 83(3):181-7. PubMed ID: 26679293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
    Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
    Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation analysis of NF-κB signal pathway-related genes in ocular MALT lymphoma.
    Liu F; Karube K; Kato H; Arita K; Yoshida N; Yamamoto K; Tsuzuki S; Kim W; Ko YH; Seto M
    Int J Clin Exp Pathol; 2012; 5(5):436-41. PubMed ID: 22808296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A20 inactivation in ocular adnexal MALT lymphoma.
    Bi Y; Zeng N; Chanudet E; Huang Y; Hamoudi RA; Liu H; Dong G; Watkins AJ; Ley SC; Zou L; Chen R; Zhu X; Du MQ
    Haematologica; 2012 Jun; 97(6):926-30. PubMed ID: 22207688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas.
    Novak U; Rinaldi A; Kwee I; Nandula SV; Rancoita PM; Compagno M; Cerri M; Rossi D; Murty VV; Zucca E; Gaidano G; Dalla-Favera R; Pasqualucci L; Bhagat G; Bertoni F
    Blood; 2009 May; 113(20):4918-21. PubMed ID: 19258598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNFAIP3 is the target gene of chromosome band 6q23.3-q24.1 loss in ocular adnexal marginal zone B cell lymphoma.
    Honma K; Tsuzuki S; Nakagawa M; Karnan S; Aizawa Y; Kim WS; Kim YD; Ko YH; Seto M
    Genes Chromosomes Cancer; 2008 Jan; 47(1):1-7. PubMed ID: 17886247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A20 (TNFAIP3) genetic alterations in EBV-associated AIDS-related lymphoma.
    Giulino L; Mathew S; Ballon G; Chadburn A; Barouk S; Antonicelli G; Leoncini L; Liu YF; Gogineni S; Tam W; Cesarman E
    Blood; 2011 May; 117(18):4852-4. PubMed ID: 21406721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A20 deletion is associated with copy number gain at the TNFA/B/C locus and occurs preferentially in translocation-negative MALT lymphoma of the ocular adnexa and salivary glands.
    Chanudet E; Ye H; Ferry J; Bacon CM; Adam P; Müller-Hermelink HK; Radford J; Pileri SA; Ichimura K; Collins VP; Hamoudi RA; Nicholson AG; Wotherspoon AC; Isaacson PG; Du MQ
    J Pathol; 2009 Feb; 217(3):420-30. PubMed ID: 19006194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent inactivation of A20 in B-cell lymphomas.
    Kato M; Sanada M; Kato I; Sato Y; Takita J; Takeuchi K; Niwa A; Chen Y; Nakazaki K; Nomoto J; Asakura Y; Muto S; Tamura A; Iio M; Akatsuka Y; Hayashi Y; Mori H; Igarashi T; Kurokawa M; Chiba S; Mori S; Ishikawa Y; Okamoto K; Tobinai K; Nakagama H; Nakahata T; Yoshino T; Kobayashi Y; Ogawa S
    Nature; 2009 Jun; 459(7247):712-6. PubMed ID: 19412163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune regulation role of A20 and its clinical significance].
    Li YQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Aug; 19(4):851-6. PubMed ID: 21867600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the nuclear factor-κB inhibitor A20 is altered in the cystic fibrosis epithelium.
    Kelly C; Williams MT; Mitchell K; Elborn JS; Ennis M; Schock BC
    Eur Respir J; 2013 Jun; 41(6):1315-23. PubMed ID: 23018911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in the genes coding for the NF-κB regulating factors IκBα and A20 are uncommon in nodular lymphocyte-predominant Hodgkin's lymphoma.
    Schumacher MA; Schmitz R; Brune V; Tiacci E; Döring C; Hansmann ML; Siebert R; Küppers R
    Haematologica; 2010 Jan; 95(1):153-7. PubMed ID: 19648161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of the TNFAIP3 (A20) tumor suppressor gene in CLL.
    Philipp C; Edelmann J; Bühler A; Winkler D; Stilgenbauer S; Küppers R
    Int J Cancer; 2011 Apr; 128(7):1747-50. PubMed ID: 20533286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-editing enzyme A20 (TNFAIP3) is a central regulator of immunopathology.
    Vereecke L; Beyaert R; van Loo G
    Trends Immunol; 2009 Aug; 30(8):383-91. PubMed ID: 19643665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrent alterations of TNFAIP3 (A20) in T-cell large granular lymphocytic leukemia.
    Johansson P; Bergmann A; Rahmann S; Wohlers I; Scholtysik R; Przekopowitz M; Seifert M; Tschurtschenthaler G; Webersinke G; Jäger U; Siebert R; Klein-Hitpass L; Dührsen U; Dürig J; Küppers R
    Int J Cancer; 2016 Jan; 138(1):121-4. PubMed ID: 26199174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.